When was Onc.ai founded?

Onc.ai was founded in 2020 and raised its 1st funding round within a year of its incorporation.

Where is Onc.ai located?

Onc.ai is headquartered in San Carlos, United States.

How many employees does Onc.ai have?

As of May 31, 2026, the latest employee count at Onc.ai is 27.

Is Onc.ai a funded company?

Onc.ai is a funded company, having raised a total of $31M across 3 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Dec 02, 2020.

When was the latest funding round of Onc.ai?

Onc.ai's latest funding was a $***** Grant (prize money) round on Sep 13, 2024, with participation from 1 investor.

Where does Onc.ai rank among its competitors?

Onc.ai ranks 10th amongst 352 active competitors, of which 97 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Techcyte, which secured $15M in Apr, 2026.

Who are the top competitors of Onc.ai?

Onc.ai's top competitors include PAIGE, PathAI and Ibex. Among them, Techcyte secured the most recent funding round in April, 2026.

Onc.ai - 2026 Company Profile, Team, Funding & Competitors

Company Details

AI-based cancer treatment and diagnosis platform for healthcare providers. The platform assists in the decision-making process for providing and aiding in cancer treatment decisions using AI technology, genomics, proteomics, radionics, and more.

Key Metrics

Founded Year

2020

Location

San Carlos, United States

Stage

Series A

Total Funding

$31M in 3 rounds

Latest Funding Round

Grant (prize money), Sep 13, 2024, $*****

Investors

MassMutual & 13 more

Ranked

10^th among 352 active competitors

Employee Count

27 as on May 31, 2026

Similar Companies

Innovaccer & 2566 more

View Onc.ai's full profile

Onc.ai has raised a total funding of $31M over 3 rounds. Its first funding round was on Dec 02, 2020. Its latest funding round was a Grant (prize money) round on Sep 13, 2024 for $*****. 1 investor participated in its latest round. Onc.ai has 10 institutional investors and 4 angel investors.

Here is the list of recent funding rounds of Onc.ai:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 13, 2024	6594947	Grant (prize money)	1793744	9781846	3891604	1356047
Jan 05, 2023	4459149	Series A	8287475	1200478	2350978	Life Extension Ventures & 4 more
Dec 02, 2020	2339522	Series A	7842698	9234415	Accomplice & 1 more	515 Ventures & 6 more

Access funding benchmarks and valuations. Sign up today!

View details of Onc.ai's funding rounds and investors

The founders of Onc.ai are Akshay Nanduri, Petr Jordan and Salmaan Ahmed.

Here are the details of Onc.ai's key team members:

Akshay Nanduri: Founder & CEO of Onc.ai and founder of 1 other company.
Contact Info: 3 email addresses
Petr Jordan: CTO, Founding Team Member of Onc.ai.
Contact Info: 1 email address
Salmaan Ahmed: VP Software, Founder of Onc.ai.

View details of Onc.ai's Founder profiles and Board Members

Onc.ai's employee count trend

Onc.ai has 27 employees as of May 26. Here is Onc.ai's employee count trend over the years:

Uncover Onc.ai's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Onc.ai include PAIGE, PathAI and Ibex. Here is the list of Top 10 competitors of Onc.ai, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PAIGE 2018, New York City (United States), Acquired	Developer of AI applications and foundation models for cancer diagnostics	$241M	Casdin Capital, Goldman Sachs & 9 others	71/100
2nd	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, Merck Global Health Innovation Fund ... & 22 others	71/100
3rd	Ibex 2016, Tel Aviv (Israel), Series C	Provider of AI-powered diagnostic solutions for pathology	$114M	83NORTH, aMoon & 6 others	69/100
4th	Deciphex 2017, Dublin (Ireland), Series C	Network of pathologists providing digital diagnostic services for medical testing	$56.6M	Seroba Life Sciences, Molten Ventures & 13 others	65/100
5th	Aignostics 2018, Berlin (Germany), Series B	Developer of artificial intelligence software for biomedical image analysis applications	$53.9M	Wellington Partners Venture Capital, Boehringer Ingelheim Venture Fund ... & 9 others	63/100
6th	Aiforia 2014, Helsinki (Finland), Public	Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas	$23M	Businessfinland, Ascend Capital Partners & 8 others	63/100
7th	Lunit 2013, Seoul (South Korea), Public	Developer of artificial intelligence solutions for cancer detection and treatment	$135M	InterVest, Shinhan Investment Corp & 24 others	62/100
8th	Techcyte 2014, Orem (United States), Series B	Artificial intelligence (AI) based image analysis platform for pathologists	$50.4M	ARUP Laboratories, Zoetis & 2 others	61/100
9th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	61/100
10th	Onc.ai 2020, San Carlos (United States), Series A	AI-based cancer treatment and diagnosis platform for healthcare providers	$31M	MassMutual, Accomplice & 12 others	61/100